Navigation Links
UNC, Caltech research finds further evidence for genetic contribution to autism
Date:7/17/2008

CHAPEL HILL Some parents of children with autism evaluate facial expressions differently than the rest of us and in a way that is strikingly similar to autistic patients themselves, according to new research by psychiatrist Dr. Joe Piven of the University of North Carolina at Chapel Hill and neuroscientist Ralph Adolphs, Ph.D., of the California Institute of Technology.

Piven, Adolphs and colleague Michael Spezio, Ph.D., formerly of Caltech but now at Scripps College in Claremont, Calif., collaborated to study 42 parents of children with autism, a complex developmental disability that affects an individual's ability to interact socially and communicate with others. Based on psychological testing, 15 of the parents were classified as being socially aloof.

"This manifests as a tendency not to prefer interactions with others, not to enjoy 'small talk' for the sake of the social experience and to have few close friendships involving sharing and mutual support," said Piven, senior author of the study, Sarah Graham Kenan professor of psychiatry in the UNC School of Medicine and director of the newly established Carolina Institute for Developmental Disabilities. "This characteristic is really a variation of normal and not associated with any functional impairment."

The parents participated in an experiment that measured how they make use of the face to judge emotions. The subjects were shown images depicting facial expressions of emotion that were digitally filtered so that only certain regions of the face were discernible the left eye, for example, or the mouth. The subjects were then asked to decide as quickly as possible if the emotion depicted was "happy" or "fear." The part of the face shown and the size of the revealed area randomly varied from trial to trial.

An analysis of the subjects' correct responses revealed that "aoof" parents relied much more heavily on the mouth to recognize emotion than they did on the eyes, as
'/>"/>

Contact: Tom Hughes
tahughes@unch.unc.edu
919-966-6047
University of North Carolina School of Medicine
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...ern California biomedical engineer and cardiologis...o help clinicians distinguish cardiac emergencies ...manageable with drugs and lifestyle change. , An...he arteries feeding the heart, offer an inside vie... vessels, often revealing deposits of a dangerous ...
(Date:11/23/2009)... and toads have existed for 360 million years and ...tic fungus is threatening to make many of them ext...e of Microbiology Today . , The fungus, Batra...ssociated with waves of amphibian extinctions in C...1990,s. Bd infects over 350 amphibian species by p...
(Date:11/23/2009)...e of General Medical Sciences (NIGMS), part of the... $42.3 million for grants in scientific areas it i...oped the GO grant program to stimulate biomedical ...he American Recovery and Reinvestment Act (Recover...ise to have a significant impact on a field of bio...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Environmental Chemicals May Affect Male Reproduction 58306 1Environmental Chemicals May Affect Male Reproduction 58306 2Dynatronics Expands Nationwide Direct Sales Force by 25 Percent 58304 1Dynatronics Expands Nationwide Direct Sales Force by 25 Percent 58304 2Saint Louis Public School District Awards Contract to Accelify 58302 1Saint Louis Public School District Awards Contract to Accelify 58302 2
...LA Research led by David Worthylake, PhD, Assista... at LSU Health Sciences Center New Orleans, may he...pound to prevent the spread of cancer. The researc...he Journal of Biological Chemistry . , During th...disease, cancer cells acquire the ability to detac...
...0 years it has become commonplace to think of Eart...tain equilibrium so that life might continue and f...ncient Greek goddess of Earth, even put forth the ...ganism, with its complex systems finely tuned to c...But actually it is the Gaia view that is out of ki...
...ms to forget things, will she end up demented? The...ms that may signal which 70-year-olds risk develop...t the Sahlgrenska Academy at the University of Got...y used to predict which elderly individuals risk d... The thesis shows that memory loss is the only fac...
Other Biology News:LSUHSC research describes function of key protein in cancer spread 2New book suggests Earth perhaps not such a benevolent mother after all 2New book suggests Earth perhaps not such a benevolent mother after all 3Early identification of dementia increasingly difficult 2
(Date:11/23/2009)...tive new study, a University of Utah scientist arg...r cause of global warming cannot be stabilized un...ds the equivalent of one new nuclear power plant e...e any substantial near-term departure from recentl... rates," says the new paper by Tim Garrett, an ass...
(Date:11/23/2009)...FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI )t...09astheex-dividenddateforits$200millionspecialdivi...ansactioncompletedonNovember2,2009.Thedividendwill...therecorddate,December1,2009.NASDAQhassettheapprox...ommonstockforpurposesoftheex-dividenddateonNovembe...
(Date:11/23/2009)...gnC or p.(IDC)announcedtodaythatDr.BruceL.A.Carter...ssfultrackrec or dinbiotechnologyexecutivemanageme...tics,inSeattle,WAandChiefScientificOfficeratNovoN ...ww.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ,...cercommented,"IamdelightedtowelcomeDr.BruceCartera...
(Date:11/23/2009)...--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),aspec...opingandcommercializingsignificantproductsprimaril...thatCraigA.Collard,PresidentandChiefExecutiveOffic...alPiperJaffrayHealthCareConferenceat3:30PMETonWedn...rkCity. ,, AliveaudioandarchivedwebcastofCorner...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2
...Pharma, Inc. (Nasdaq:,GORX) announced today that i...ts of its third fiscal quarter ended December 31, ...ET) with CEO, Mihir Taneja and VP/CFO,Carol Dore-F...erence call,by utilizing the following URL, http:/...?key=PVYY97BW8 thus,avoiding operator assistance ...
... Schering-Plough,Corporation (NYSE: SGP ) today ...on (FDA) has accepted the Peg-IFN (peginterferon a... (sBLA) for review and has,granted Priority Review...h,Stage III melanoma. Schering-Plough submitted it... The Priority Review designation is intended to ex...
...help doctors and clinicians identify best t...ease, BIRMINGHAM, Ala., Jan. 31 Clinical trial r...ation point to the need for more,detailed choleste...nd other,lipids. That,s according to Atherotech, a...xpanded cholesterol test called the VAP (Vertical ...
Other Biology Technology:GeoPharma Announces Third Quarter Conference Call 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 2FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 3FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 4FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 5FDA Grants Priority Review for Schering-Plough's Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma 6Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 2Atherotech Says Detailed Cholesterol Test Can Help Doctors and Patients Choose Best Therapy 3
Goat Anti-Human Rabenosyn 5 Polyclonal Antibody, Unconjugated from Abcam
Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119] NON-neutralizing Polyclonal Antibody, Unconjugated from Cell Sciences
Anti-AANAT Antibody, Unconjugated from CHEMICON
Biology Products: